2018 China's pharmaceutical exports steady growth can be expected | The development of pharmaceutical trade in general to the good

According to China's customs statistics, in 2017, the import and export volume of China's medical and health products was 116.676 billion U.S. dollars, up 12.64% over the same period of 2006. Of this total, the exports were 60.799 billion U.S. dollars, reversing the decline of the previous year, an increase of 9.44 %, An increase of nearly 5 years the highest value.China Medicines and Health Products Import and Export Chamber of Commerce vice president Meng Dongping said that in 2017, China's pharmaceutical export structure to further optimize the new momentum of development is being formed, the overall development of pharmaceutical trade to the general good.

The export of traditional Chinese medicine was up by 4.33%; the export of proprietary Chinese medicine was 250 million U.S. dollars, up 11.03% over the same period of last year; ; In Medicinal herbs And Pieces exports continued to grow negative, down 2.23%.

In 2017, the export of western medicine products in China was 35.456 billion U.S. dollars, up 12.62%, of which 29.117 billion U.S. dollars was in the export of APIs, an increase of 13.71% over the same period of last year. The raw material pharmaceutical companies' environmental protection costs continued to rise, prompting supply side contraction and backward production capacity Gradual withdrawal, the competitive pattern of high-quality enterprises continued to improve. Preparations exports 34.56 billion US dollars, an increase of 8.32%, on the EU, North American regulatory market strong growth in the formulation of the export market, research and development of innovative pharmaceutical companies gradually become the main export drive export agents, foreign investment The export of pharmaceutical enterprises increased sharply to 1.884 billion U.S. dollars, up 32.61% over the same period of last year.

medical instruments Exports increased steadily in 2017. The export amount of medical devices was 21.703 billion U.S. dollars, up by 5.84% over the same period of 2017. Among them, medical dressings, disposable consumables, diagnostic and therapeutic equipment, health Recover equipment, dental equipment have achieved steady growth, growth rates were 2.97%, 9.53%, 4.11%, 6.29% and 17.00%. 'At present, China's pharmaceutical enterprise In the international registration of certification, research and development, international marketing, resource integration and other aspects of the global capacity continued to improve, the pharmaceutical export product landscape and market patterns are undergoing profound changes in the international pharmaceutical trade environment to the overall good. In terms of favorable factors, the demand for major export markets such as the United States, the European Union and India is recovering and is expected to maintain steady growth. Products such as preparations and medical devices have obviously accelerated their exports to the European and American markets. Bulk pharmaceutical raw materials and medical device products have enjoyed significant growth in the global pharmaceutical market Rigid demand has not changed, and exports and prices are gradually picking up along with the global economic recovery.

Although the uncertainties in the markets such as South America and Africa still exist, the trade friction situation of pharmaceutical products is even more severe. However, with the implementation of the 13th Five-Year Plan for the Pharmaceutical Industry, China medicine The industry will develop in a more orderly, higher-tech, value-added and resource-saving direction and will continue to extend downstream so that it will be more conducive to the continuous optimization and upgrading of its export structure. The SAIC estimates that in 2018, China's pharmaceutical foreign trade will continue to maintain The steady development of the fundamentals.